These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2882053)

  • 1. Somatostatin analogs with improved oral bioavailability.
    Nutt RF; Colton CD; Veber DF; Slater EL; Saperstein R
    Klin Wochenschr; 1986; 64 Suppl 7():71-3. PubMed ID: 2882053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
    Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A super active cyclic hexapeptide analog of somatostatin.
    Veber DF; Saperstein R; Nutt RF; Freidinger RM; Brady SF; Curley P; Perlow DS; Paleveda WJ; Colton CD; Zacchei AG
    Life Sci; 1984 Apr; 34(14):1371-8. PubMed ID: 6143233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational modifications of cyclic hexapeptide somatostatin analogs.
    Freidinger RM; Perlow DS; Randall WC; Saperstein R; Arison BH; Veber DF
    Int J Pept Protein Res; 1984 Feb; 23(2):142-50. PubMed ID: 6142021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.
    Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH
    Peptides; 1982; 3(5):811-4. PubMed ID: 6129618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.
    Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH
    Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
    Garsky VM; Clark DE; Grant NH
    Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine.
    Brady SF; Cochran DW; Nutt RF; Holly FW; Bennett CD; Paleveda WJ; Curley PE; Arison BH; Saperstein R; Veber DF
    Int J Pept Protein Res; 1984 Feb; 23(2):212-22. PubMed ID: 6142022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin agonists and antagonists--peptide control of growth hormone secretion.
    Coy DH; Murphy WA; Lance VA; Hocart SJ; Sueiras-Diaz J; Mezo I
    Adv Exp Med Biol; 1985; 188():325-37. PubMed ID: 2863940
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
    Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
    J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon releasing activity of a cyclic peptide related to somatostatin.
    Lyle TA; Freidinger RM; Nutt RF; Homnick CF; Saperstein R; Veber DF
    Int J Pept Protein Res; 1987 Feb; 29(2):244-9. PubMed ID: 2883151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs which define the role of the lysine-9 amino group.
    Nutt RF; Veber DF; Curley PE; Saperstein R; Hirschmann R
    Int J Pept Protein Res; 1983 Jan; 21(1):66-73. PubMed ID: 6131045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic hexapeptides related to somatostatin. Synthesis and biological testing.
    Pattaroni C; Lucietto P; Goodman M; Yamamoto G; Vale W; Moroder L; Gazerro L; Göhring W; Schmied B; Wünsch E
    Int J Pept Protein Res; 1990 Nov; 36(5):401-17. PubMed ID: 1980489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F; Kamber B; Rink H; Sieber P
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.